Gilead to buy certain Hookipa Pharma assets for up to $10M SA News Thu, May 22. HOOKIPA Pharma Inc. SEC Filing - Quarterly Report (10-Q) May 15, 2025 SEC Filings Thu, May 15.

Patritumab deruxtecan (HER3-DXd; MK-1022) is an investigational HER3-directed antibody-drug conjugate composed of a human immunoglobulin G1 monoclonal antibody to HER3 (patritumab) covalently linked ...

See the latest Gilead Sciences GILD stock price (NASDAQ: GILD), related news, valuation, dividends and more to help you make your investing decisions.

Gilead Sciences has joined the list of pharma groups hiking their capital investment plans in the US, adding $11 billion in new spending as the industry prepares for potential sector-specific tariffs.

Gilead Sciences has achieved success with its HIV treatment drugs, including tenofovir disoproxil fumarate, but faces criticism for pricing and access issues. Learn about the controversy and ...

HOOKIPA Pharma Inc. (HOOK, HOOKIPA) today announced that the first person has been dosed in a Phase 1b clinical trial of HB-500,... By Investing.com • Jul 01, 2024 ...

A high-level overview of Gilead Sciences, Inc. (GILD) stock. View (GILD) real-time stock price, chart, news, analysis, analyst reviews and more.

Review quarterly and annual revenue, net income, and cash flow for Gilead Sciences Inc (GILD:XNAS) stock through the last fiscal year.

Watch the surfers at Ho'okipa Beach Park is ranked #20 out of 29 things to do in Maui. See pictures and our review of Watch the surfers at Ho'okipa Beach Park.

Find the latest historical data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. View historical data in a monthly, bi-annual, or yearly format.